Traditional Chinese medicine for myasthenia gravis
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This trial tests if a traditional Chinese herbal formula, Bu Zhong Yi Qi Tang, can help people with ocular myasthenia gravis. It combines the herbal treatment with standard Western medicine to see if it improves symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ocular myasthenia gravis by a doctor.
- You are 20 years old or older.
- You can speak Mandarin or Taiwanese.
- You are willing to receive both Western and traditional Chinese medicine together.
- You do not have liver failure, kidney failure, or a malignant tumor.
- You are not pregnant and do not have a cardiac rhythm device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses tongue imaging and traditional Chinese medicine methods to compare tongue features between people with myasthenia gravis and healthy individuals. It may help understand how tongue diagnosis relates to this condition.
This study follows people with suspected or confirmed myasthenia gravis (a condition that causes muscle weakness that gets worse with use). It uses several specialized nerve and antibody tests to make a more precise diagnosis and tracks you over time to see how well these methods work.
This trial tests an experimental oral medication called NMD670 for people with myasthenia gravis (MG). It aims to see if the drug is safe and if it helps improve muscle strength and daily function.
This study creates a registry to collect information about people with myasthenia gravis in China. By joining, you help researchers learn more about the condition and how it affects different people.
This study follows people with myasthenia gravis who are patients at Peking Union Medical College Hospital to learn more about the disease and how it affects patients over time.
This trial tests a new medicine called telitacicept combined with low-dose steroids for people with hard-to-treat myasthenia gravis. The goal is to see if this combination can better control symptoms that haven't improved with standard treatments.
Hear when a new Myasthenia Gravis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.